Nearly 1,100 New Zealand consumers walked into a virtual supermarket and chose between the familiar and the future. In this choice experiment, they faced milk from conventional cows alongside three forms of gene-edited dairy—including an allergy-free version and another with purported COVID-protection features. The results, published in Future Foods, reveal something unexpected: consumers aren't inherently opposed to gene-edited milk. What they want is clear value and a fair price.
The stakes of this research are grounded in the reality facing New Zealand's farmers. As temperatures rise, heat stress reduces milk production and harms animal welfare, all while lowering the environmental efficiency of dairy farming. For a nation whose economy leans heavily on dairy exports, the pressure is real. Scientists have been exploring whether gene editing can help—creating cattle that cope better with warmer temperatures while producing fewer methane emissions. But science alone isn't enough. The products need consumers willing to buy them.
Gene editing works differently from traditional genetic modification, allowing specific tweaks to DNA without necessarily introducing new genetic material. This precision appeals to some researchers as potentially more acceptable to the public. To test this theory, researchers didn't hand people actual gene-edited milk—because such products don't yet exist commercially. Instead, they presented hypothetical scenarios and asked consumers to repeatedly choose their preferred options across various pricing and benefit combinations. The experiment mimicked real supermarket decisions, examining not just attitudes but the trade-offs people would actually make.
The findings revealed a nuanced picture. Conventional milk remained the most preferred option overall—unsurprising, since consumers trust familiar foods, especially everyday staples. But resistance to gene-edited alternatives proved neither fixed nor particularly strong. When gene-edited milk was priced lower than conventional varieties, acceptance jumped significantly. Price, it turned out, was a genuine lever.
More intriguing was the role of tangible benefits. Allergy-free milk emerged as the clear winner among the gene-edited options tested. This suggests consumers are willing to embrace food technologies when they can directly see how a product improves their lives. An allergy-free claim is concrete and easy to grasp—a parent with a child suffering from dairy allergies can immediately recognize the value. By contrast, broader environmental or technical claims felt abstract to many shoppers. The COVID-protection version, while appealing to some, carried the baggage of pandemic fatigue and a more complex health proposition that was harder to articulate and understand.
The research points toward a pathway forward, though not the one some technologists might have envisioned. Gene-edited foods may not succeed by replacing conventional options overnight. Instead, they're likely to build consumer trust gradually, one clear benefit at a time. As climate pressures intensify worldwide and food systems face difficult trade-offs between sustainability, affordability and productivity, technologies like gene editing may become increasingly attractive—especially when they deliver targeted solutions faster than conventional breeding methods. The lesson from New Zealand's consumers is straightforward: show us what's in it for us, keep it simple, and price it fairly. Do that, and the future of dairy might look very different indeed.